ProMIS Neurosciences, Inc.
PMN
$0.52
$0.0193.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 121.03% | 96.67% | 40.47% | 43.19% | 26.85% |
| Total Depreciation and Amortization | -- | 282.98% | 144.00% | 101.03% | 88.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,953.80% | -808.11% | 82.49% | 72.32% | 87.10% |
| Change in Net Operating Assets | -498.35% | -221.36% | -170.56% | -185.16% | -45.50% |
| Cash from Operations | -150.67% | -90.95% | -29.01% | -14.45% | 36.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.15% | -- | -- | -- | -- |
| Cash from Investing | 46.15% | -- | -- | -- | 38.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 52.67% | 17.96% | 270.90% | 270.90% | 267.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 57.06% | 8.65% | 176.21% | 176.21% | 173.28% |
| Foreign Exchange rate Adjustments | -- | 100.00% | 14.49% | 71.08% | 65.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.69% | -63.94% | 97.00% | 91.99% | 160.74% |